Citigroup Inc., one of the largest financial institutions in the United States, has recently reduced its stake in Quaker Chemical Co. The company sold approximately 9.4% of its shares during the first quarter of this year, as reported in its Form 13F filing with the Securities and Exchange Commission (SEC). As a result, Citigroup Inc. now owns around 11,003 shares of Quaker Chemical stock, which is equivalent to approximately 0.06% of the company’s total market value. Based on the most recent SEC filing, these shares are estimated to be worth $2,178,000.
Quaker Chemical is a leading specialty chemicals company listed on the New York Stock Exchange (NYSE) under the ticker symbol KWR. The company recently announced its quarterly earnings results on August 1st. According to the report, Quaker Chemical achieved earnings per share (EPS) of $1.93 for the quarter. This figure exceeded analysts’ consensus estimates by $0.08 per share.
In addition to surpassing earnings expectations, Quaker Chemical also demonstrated positive performance in terms of profitability measures. The company’s net margin stood at 0.45%, indicating that it effectively managed its costs and expenses during this period. Moreover, Quaker Chemical displayed a return on equity (ROE) of 9.59%, which highlights its ability to generate profits from shareholders’ investments.
Despite these impressive figures, there was a slight decline in revenue compared to analyst predictions for the quarter. While analysts estimated revenue to reach $507 million for this period, Quaker Chemical reported revenue of $495.44 million instead—a difference of about $11 million or approximately 2%. However, despite this minor setback, it is essential to note that Quaker Chemical experienced a revenue increase of 0.6% compared to the same quarter last year.
Looking ahead into the current fiscal year, equities analysts remain optimistic about Quaker Chemical’s performance. They expect the company to post earnings per share of 7.46 for the year, indicating anticipated growth and continued profitability for Quaker Chemical Co.
Citigroup Inc.’s decision to reduce its position in Quaker Chemical, though relatively small in percentage terms, may reflect a strategic move on their part. While it is unclear what motivated this reduction, investors and market observers will likely monitor future developments regarding Citigroup Inc.’s stake in Quaker Chemical.
Overall, Quaker Chemical Co.’s recent earnings report showcases its ability to deliver strong financial results despite a challenging economic environment. The company’s solid earnings per share, net margin, and return on equity indicate the effectiveness of its operations and management. As it moves forward into the current fiscal year, Quaker Chemical can leverage this positive momentum to maintain its market position and drive further growth within the specialty chemicals industry.
Quaker Chemical Corporation
KWR
Buy
Updated on: 03/12/2023
Financial Health
Healthy
Debt to equity ratio: Buy
Price to earnings ratio: Strong Sell
Price to book ratio: Strong Buy
DCF: Strong Buy
ROE: Neutral
Quaker Chemical: Institutional Investment Analysis and Dividend Increase – September 7, 2023
September 7, 2023 – Quaker Chemical: An Analysis of Recent Investment Moves and Dividend Increase
Institutional investors play a significant role in the financial market by either adding or reducing their stakes in various companies. This article focuses on the recent investment moves in Quaker Chemical, as well as the company’s dividend increase.
Strs Ohio, a prominent institutional investor, bought a new position in shares of Quaker Chemical during the first quarter of this year. This newly acquired position was valued at approximately $39,000. Similarly, Venturi Wealth Management LLC also entered the scene by purchasing a new position in the specialty chemicals company valued at $59,000 during the same period. Tower Research Capital LLC TRC demonstrated its faith in Quaker Chemical by increasing its position in the company by 17.6% during the first quarter. The current value of Tower Research Capital LLC TRC’s shares is estimated to be around $64,000 after an additional purchase of 49 shares last quarter.
US Bancorp DE took an even more substantial position in Quaker Chemical by raising its stake by 30.2% during the first quarter. With an investment of $131,000 and an additional purchase of 175 shares, they expressed their confidence in the future prospects of the company. Lastly, Bessemer Group Inc., another institutional investor, viewed Quaker Chemical as a potentially lucrative opportunity and purchased a new position worth approximately $151,000.
These investments from various institutional players emphasize their belief in Quaker Chemical’s ability to generate long-term returns and add credibility to its growth strategy.
As of September 7th, Quaker Chemical’s stock opened at $171.11 with a 50-day moving average price of $184.30 and a 200-day moving average price of $190.65. Over the past year alone, the stock has experienced considerable volatility with a low point recorded at $129.06 and a high point of $216.45. The company boasts a quick ratio of 2.05, a current ratio of 2.84, and a debt-to-equity ratio of 0.65.
With a market capitalization amounting to $3.08 billion, Quaker Chemical positions itself as a significant player in the specialty chemicals industry. However, it is crucial to consider other financial metrics such as the company’s price-to-earnings (P/E) ratio, which currently stands at 364.05, indicating that investors are willing to pay significantly more for each dollar of earnings generated by the company.
Furthermore, when assessing the growth potential of Quaker Chemical, the PEG ratio is an important metric to evaluate. With a PEG ratio of 1.15, Quaker Chemical presents an intriguing investment opportunity since this figure suggests that its stock may be undervalued compared to its projected earnings growth rate.
In recent news, Quaker Chemical announced an increase in its quarterly dividend payment schedule. Shareholders of record on Tuesday, October 17th will receive a dividend worth $0.455 per share on Tuesday, October 31st. This represents an increase from the company’s previous quarterly dividend of $0.44.
The new annualized dividend amounts to $1.82 per share and offers investors a yield of approximately 1.06%. Despite this increase, it is essential to note that Quaker Chemical’s current dividend payout ratio (DPR) stands at an impressive 370.21%.
Several analysts have shared their thoughts on Quaker Chemical’s performance and prospects in recent reports and research analyses.
StockNews.com issued a “hold” rating for shares of Quaker Chemical in their research report released on Thursday, August 17th. Stifel Nicolaus also provided coverage for Quaker Chemical by giving it a “buy” rating along with a price target of $250.00 in their report published on Thursday, June 1st. Lastly, Royal Bank of Canada raised Quaker Chemical’s price objective from $227.00 to $232.00 and rated the company as “outperform” in a report released on Thursday, August 3rd.
In conclusion, the recent investment moves made by institutional investors in Quaker Chemical signify their confidence in the company’s performance and future growth possibilities. Additionally, the dividend increase reflects Quaker Chemical’s commitment to rewarding its shareholders and promoting long-term investor loyalty. With favorable ratings from analysts and promising financial metrics, Quaker Chemical is undoubtedly a stock worth considering for potential investors seeking opportunities in the specialty chemicals industry.
Disclaimer: The information provided above is based on publicly available data as of September 7, 2023. This article should not be considered as financial advice and readers are encouraged to perform thorough research before making any investment decisions.
Discussion about this post